Baltimore Sun
Stanley Rodbell
July 13, 2017
In his commentary, “Marylanders misled by drug pricing bill” (July 12), Chester “Chip” Davis Jr. complains that generics are unreasonably targeted by the new bill. His claim is wrong. Contrary to the generic manufacturers saying that they are the “good guys,” they’re not.
I just bought a generic drug in Paris for $2.92. Here its usual and customary cost is $183.99 with my co-pay at $50. It’s ridiculous that my insurance picked up the $133.99. At least six manufacturers make this generic medication, yet competition hasn’t had the usual cost lowering effect.The price in Canada is $29 so why is it $183.99 here? Because they have pricing power and use it. I applaud the bill and think branded drugs should eventually be added.
Last modified: July 18, 2017
